These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12202674)

  • 1. Unusual hematologic malignancies. Case 1. Hematologic malignancy presenting with diarrhea and bony lesions: systemic mastocytosis.
    Tao J; Flaherty K; Bagg A
    J Clin Oncol; 2002 Sep; 20(17):3737-9. PubMed ID: 12202674
    [No Abstract]   [Full Text] [Related]  

  • 2. An unexpected association of hematologic malignancies.
    Athanase N; Frébet E
    Blood; 2018 Oct; 132(14):1545. PubMed ID: 30287471
    [No Abstract]   [Full Text] [Related]  

  • 3. Mastocytosis presenting as a skeletal disorder.
    Delsignore JL; Dvoretsky PM; Hicks DG; O'Keefe RJ; Rosier RN
    Iowa Orthop J; 1996; 16():126-34. PubMed ID: 9129284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 64-year-old woman with diarrhea and increased abdominal girth.
    Shih HH; Law RJ; Leise MD
    Mayo Clin Proc; 2015 Apr; 90(4):e35-9. PubMed ID: 25841264
    [No Abstract]   [Full Text] [Related]  

  • 5. Bone marrow mastocytosis associated with IgM kappa plasma cell myeloma.
    Stellmacher F; Sotlar K; Balleisen L; Valent P; Horny HP
    Leuk Lymphoma; 2004 Apr; 45(4):801-5. PubMed ID: 15160959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bone involvement in systemic mastocytosis: report of 3 cases].
    López-Gómez M; Mediavilla García J; Omar M; Sampalo Lainz A; Jiménez-Alonso J
    An Med Interna; 1991 Aug; 8(8):395-7. PubMed ID: 1768751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoblastic lesions in systemic mastocytosis associated with hematological malignancy.
    Gener Ricós G; Xicoy Cirici B; Tapia Melendo G
    Med Clin (Barc); 2021 May; 156(9):469-470. PubMed ID: 32461026
    [No Abstract]   [Full Text] [Related]  

  • 8. [Bone involvement with osteolytic predominance in systemic mastocytosis. A clinical case].
    Buchon R; Schoenenberger P; Vicens JL; Flageat J
    J Radiol; 1992; 73(8-9):443-9. PubMed ID: 1474520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggressive systemic mastocytosis presenting with hepatic cholestasis.
    Kupfer SS; Hart J; Mohanty SR
    Eur J Gastroenterol Hepatol; 2007 Oct; 19(10):901-5. PubMed ID: 17873616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow disorders: recent advances, Part II. Introduction.
    Torlakovic EE; Porwit A; Butany J
    Semin Diagn Pathol; 2012 Feb; 29(1):1. PubMed ID: 22372200
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms.
    Valent P; Sperr WR; Schwartz LB; Horny HP
    J Allergy Clin Immunol; 2004 Jul; 114(1):3-11; quiz 12. PubMed ID: 15241337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic mastocytosis, an unusual cause of osteoporosis.
    Schoenaers P; De Clerck LS; Timmermans U; Stevens WJ
    Clin Rheumatol; 1987 Sep; 6(3):458-62. PubMed ID: 3442970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Systemic mastocytosis].
    Redondo Mateo J; Vaquero Perez M; Guinea Esquerdo L
    Med Cutan Ibero Lat Am; 1990; 18(3):162-6. PubMed ID: 2263092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical myeloproliferative disorders in adults.
    Zachée P
    Transfus Apher Sci; 2011 Apr; 44(2):211-21. PubMed ID: 21402312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mast Cell Disorders, Melanoma and Pancreatic Carcinoma: From a Clinical Observation to a Brief Review of the Literature.
    Paolino G; Belmonte M; Trasarti S; Santopietro M; Bizzoni L; Riminucci M; Cardarelli L; Iannella E; Albanesi M; Moliterni E; Didona D; Calvieri S; Foà R; Giona F
    Acta Dermatovenerol Croat; 2017 Jul; 25(2):112-119. PubMed ID: 28871925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic mastocytosis with review of gastrointestinal manifestations.
    Fishman RS; Fleming CR; Li CY
    Mayo Clin Proc; 1979 Jan; 54(1):51-4. PubMed ID: 759738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Systemic mastocytosis].
    Szabó T; Kelemen J; Tamáska J; Gaál M; Molnár E; Winkler V; Jákó J; Bálint G
    Orv Hetil; 1997 May; 138(20):1267-71. PubMed ID: 9244861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Systemic mastocytosis with portal hypertension and hepatocellular failure].
    Vincenzi V; Costan Biedo F; Carrabba E; Benvegnu B; Furlanetto A; Baseví A
    Minerva Med; 1992 Sep; 83(9):563-5. PubMed ID: 1436608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic mastocytosis: a diagnostic challenge.
    Bateman HE; Shroff V; Centeno LV; Bielory L
    Ann Allergy Asthma Immunol; 1995 May; 74(5):379-86. PubMed ID: 7749967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 41-year-old man with a vertebral fracture and bone marrow mastocytosis.
    Makras P; Kokkoris P
    J Musculoskelet Neuronal Interact; 2010 Dec; 10(4):290-2. PubMed ID: 21116068
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.